Medshine Discovery patents new sGC activators for diabetic and hypertensive nephropathy
Nov. 21, 2022
Medshine Discovery Inc. has disclosed derivatives of a six-membered heteroaromatic urea ring acting as soluble guanylate cyclase (sGC) activators reported to be useful for the treatment of diabetic and hypertensive nephropathy.